Recombinant Bordetella pertussis ATP synthase subunit a (atpB) refers to the recombinant production of the α-subunit of the ATP synthase complex in B. pertussis. ATP synthase is a critical enzyme for bacterial energy production, catalyzing ATP synthesis via proton motive force across cellular membranes. Subunit a is part of the transmembrane F₀ subcomplex, forming proton channels and interacting with the F₁ subcomplex to drive ATP synthesis .
Energy Metabolism: ATP synthase is essential for maintaining cellular energy homeostasis, particularly during infection. B. pertussis relies on ATP synthase for colonization and toxin secretion (e.g., pertussis toxin) .
Antibiotic Targets: ATP synthase inhibitors (e.g., bedaquiline) disrupt bacterial energy production. Recombinant atpB could aid in studying drug resistance mechanisms or identifying novel targets .
Recombinant atpB production in B. pertussis faces challenges due to:
Low Expression in Native Hosts: B. pertussis often requires heterologous systems (e.g., E. coli) for efficient protein expression, as seen with fimbriae and pertussis toxin .
Post-Translational Modifications: Proper folding and membrane integration of subunit a may require chaperones or specific host environments .
KEGG: bpe:BP3282
STRING: 257313.BP3282
The choice of expression system for recombinant B. pertussis atpB depends on research objectives and desired protein characteristics. While E. coli expression systems offer simplicity and high yields, they often fail to produce native conformations of Bordetella proteins due to differences in post-translational modification pathways. Studies have demonstrated that closely related Bordetella species such as B. parapertussis and B. bronchiseptica can serve as more suitable hosts for expressing recombinant B. pertussis proteins in their native conformation . When expressing atpB, consider the following systems:
Homologous expression (within other Bordetella species) - Preserves native protein structure and folding
E. coli with optimized codons and specific translation initiation regions (TIRs)
Cell-free protein synthesis systems for difficult-to-express membrane proteins
The choice between these systems should be guided by whether functional activity or structural studies are prioritized in your research.
The selection of promoters significantly impacts expression levels of recombinant atpB. Research has shown that B. pertussis native promoters function effectively in related Bordetella species, while E. coli promoters show variable efficacy across Bordetella species . A comparative analysis reveals:
| Promoter Type | Expression in B. parapertussis | Expression in B. bronchiseptica | Notes |
|---|---|---|---|
| Native B. pertussis | High | High | Optimal for maintaining native expression patterns |
| E. coli PLAC | Minimal/None | Moderate | Functions in B. bronchiseptica but not B. parapertussis |
| Lambda PL/PR | None | None | Not effective in either species |
For atpB expression, the distance between transcription start site and translation start codon must be optimized, as seen with other B. pertussis proteins where this distance can be substantial (e.g., 146 nucleotides for fimbrial proteins) . Using the native B. pertussis promoter with its Shine-Dalgarno sequence typically yields the highest expression levels across Bordetella species.
ATP synthase subunit a (atpB) presents specific challenges as a membrane-associated protein:
Hydrophobicity and membrane integration requirements can lead to protein aggregation or misfolding
Potential toxicity to host cells when overexpressed
Difficulty in purification while maintaining native conformational states
Requirement for appropriate membrane mimetics during purification and analysis
Successful expression strategies often involve using lower induction temperatures (16-20°C), specialized E. coli strains designed for membrane proteins (C41/C43), or utilizing mild detergents like DDM (n-Dodecyl β-D-maltoside) during extraction. For functional studies, reconstitution into proteoliposomes may be necessary to maintain the protein's native environment.
Developing effective reporter systems for atpB requires strategies that accommodate its membrane localization:
C-terminal fusion tags (His, FLAG, or GFP variants) with flexible linkers to minimize interference with membrane insertion
Split GFP systems where the 11th β-strand of GFP is fused to atpB and complemented by the remainder of GFP in the cytoplasm
Inducible promoter systems to control expression timing
For microscopy-based localization studies, consider using specialized GFP variants that fold efficiently in the periplasmic or membrane environment. When designing reporter constructs for atpB, it's critical to verify that fusion proteins maintain proper membrane integration and function, as incorrect folding can redirect proteins to inclusion bodies.
Purification of membrane proteins like atpB requires careful consideration of extraction and purification conditions:
| Parameter | Recommended Approach | Rationale |
|---|---|---|
| Detergent selection | Mild detergents (DDM, LMNG) | Maintain protein-protein interactions within ATP synthase complex |
| Buffer composition | 25-50 mM Tris-HCl pH 8.0, 100-300 mM NaCl, 5-10% glycerol | Stabilize extracted protein |
| Temperature | 4°C throughout purification | Minimize proteolytic degradation |
| Purification strategy | Two-step: affinity chromatography followed by size exclusion | Remove impurities while maintaining native oligomeric state |
| Reconstitution | Gradual detergent removal by dialysis or biobeads | Allow proper refolding into lipid bilayers |
For structural studies requiring higher purity, consider incorporating an ion exchange chromatography step between affinity and size exclusion steps. The presence of appropriate lipids (typically E. coli polar lipid extract at 10:1 lipid:protein ratio) during purification can significantly enhance stability and activity of the purified atpB.
For researchers pursuing NMR or mass spectrometry studies of atpB:
Minimal media formulations must be optimized to achieve sufficient cell density while incorporating isotope-labeled precursors
Expression in deuterated media requires adaptation periods for host cells
Selective labeling strategies can focus on specific amino acids involved in functional regions
An effective approach combines SILAC (Stable Isotope Labeling by Amino acids in Cell culture) techniques with controlled expression timing. Begin with a pre-culture in rich media, then transfer to minimal media containing isotope-labeled precursors, followed by a short adaptation period before induction. This methodology has been successfully applied to other membrane proteins from pathogenic bacteria and can be adapted for atpB studies.
Assessing proper assembly of recombinant atpB within the ATP synthase complex requires multiple complementary approaches:
Blue Native PAGE to analyze intact complex formation
ATP hydrolysis assays comparing activity of complexes with recombinant versus native atpB
Proton pumping assays using pH-sensitive fluorophores in reconstituted proteoliposomes
Cross-linking studies followed by mass spectrometry to verify interaction partners
When properly assembled, atpB should demonstrate interactions with other ATP synthase subunits and contribute to proton translocation coupled to ATP synthesis/hydrolysis. Comparison with known ATP synthase inhibitors (oligomycin, DCCD) can provide further evidence of functional integration, as properly assembled complexes will show characteristic inhibition patterns.
The membrane environment critically impacts atpB function since it forms part of the proton channel in ATP synthase. Research on membrane proteins indicates:
Lipid composition affects protein lateral mobility and conformational changes
Membrane thickness influences hydrophobic matching with transmembrane domains
Presence of specific lipids (cardiolipin, phosphatidylethanolamine) can be essential for function
For functional studies, reconstructed systems should mimic the native Bordetella membrane environment. While exact lipid compositions for B. pertussis membranes are not fully characterized, systems using E. coli polar lipid extract supplemented with 10-20% cardiolipin have proven effective for other bacterial ATP synthases. Nanodiscs containing defined lipid compositions offer advantages for controlled studies of lipid effects on atpB function.
To rigorously compare recombinant and native atpB:
Site-directed mutagenesis of conserved residues should produce similar functional effects in both proteins
Thermal stability profiles measured by differential scanning calorimetry can reveal differences in folding quality
Hydrogen-deuterium exchange mass spectrometry can identify regions with altered conformational dynamics
Inhibitor binding profiles and kinetics should match between native and recombinant forms
Additionally, cryo-EM structural analysis of ATP synthase complexes containing either native or recombinant atpB can provide direct visualization of any structural differences. When designing such comparative studies, it's essential to purify both proteins using identical methods to eliminate methodological variables.
Recombinant atpB provides a valuable tool for studying metabolic adaptation during infection:
Tagged versions can monitor expression levels during different growth conditions mimicking host environments
Mutational analysis can identify regions involved in regulatory protein-protein interactions
In vitro reconstitution with regulatory factors can elucidate control mechanisms
Research on other pathogens has shown that ATP synthase regulation is often linked to virulence factor expression through shared regulatory networks . For B. pertussis, the relationship between energy metabolism and toxin production represents an important research area. Studies using recombinant atpB can help determine if ATP synthase activity serves as a metabolic checkpoint for virulence factor production, similar to what has been observed with pertussis toxin regulation .
The ATP synthase complex, including atpB, is increasingly recognized as important for bacterial persistence:
During nutrient limitation, bacteria often downregulate ATP synthase to minimize energy expenditure
Some antibiotics require active metabolism for efficacy, making ATP synthase regulation relevant to tolerance mechanisms
Membrane potential maintenance, partially regulated by ATP synthase activity, affects susceptibility to certain antimicrobials
Recombinant atpB variants can be used to create strains with altered ATP synthase activity to study these phenomena. By combining controlled expression systems with metabolic measurements, researchers can establish causative relationships between energy metabolism and persistence phenotypes in B. pertussis.
ATP synthase has emerged as a potential antibiotic target, with atpB forming part of the critical proton channel:
High-resolution structures of atpB can identify unique pockets absent in human homologs
Fragment-based screening against purified recombinant atpB can identify initial chemical scaffolds
Mutations in atpB affecting antibiotic binding sites can provide resistance mechanisms information
While bedaquiline (targeting mycobacterial ATP synthase) demonstrates the viability of ATP synthase as an antibiotic target, species-specific differences in ATP synthase structure are critical for developing selective inhibitors. Recombinant B. pertussis atpB provides the necessary material for structural and biochemical studies to identify unique features that could be exploited for selective targeting.
Membrane proteins like atpB require specialized approaches for interaction studies:
Membrane-based yeast two-hybrid systems that allow interaction detection within membrane environments
Proximity labeling using BioID or APEX2 fused to atpB to identify nearby proteins in vivo
Co-immunoprecipitation with crosslinking to capture transient interactions
Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
For ATP synthase components, chemical crosslinking followed by mass spectrometry has proven particularly valuable in identifying interaction regions between subunits. When applying these techniques to B. pertussis atpB, expression levels must be carefully controlled to avoid artifacts from overexpression, which can disrupt normal stoichiometry within the ATP synthase complex.
Energy dependency of toxin secretion systems can be studied using recombinant atpB variants:
Develop expression systems with tunable atpB activity through directed mutagenesis
Create reporter systems that simultaneously monitor ATP synthase activity and toxin secretion
Establish reconstituted systems combining purified recombinant atpB with secretion apparatus components
In B. pertussis, toxin secretion systems require energy input that may directly or indirectly depend on ATP synthase activity . Experimental designs should include measurements of membrane potential, ATP levels, and proton motive force alongside quantification of toxin secretion. Comparing wild-type atpB with mutant variants can establish the specific contributions of ATP synthase to secretion energetics.
Post-translational modifications (PTMs) of bacterial ATP synthase components are increasingly recognized as regulatory mechanisms:
Phosphorylation and acetylation can be detected using modification-specific antibodies or mass spectrometry
Enrichment strategies for modified peptides are essential due to substoichiometric modification levels
Site-directed mutagenesis of modified residues can establish functional significance
To comprehensively analyze PTMs on recombinant atpB, consider:
| PTM Type | Detection Method | Enrichment Strategy | Control/Validation |
|---|---|---|---|
| Phosphorylation | LC-MS/MS | TiO₂ or IMAC | Lambda phosphatase treatment |
| Acetylation | LC-MS/MS | Anti-acetyllysine antibodies | Deacetylase treatment |
| S-Nitrosylation | Biotin switch technique | Streptavidin pulldown | Ascorbate dependence |
| Oxidation | LC-MS/MS | No specific enrichment | Reduction/oxidation controls |
When comparing PTM patterns between native and recombinant atpB, consider that expression host and growth conditions significantly impact modification profiles, requiring careful experimental design to distinguish biologically relevant modifications from artifacts.